Learn more Webcast featuring eSpOT-ON
Explore More eSpOT-ON Nuclease Protein Available Now
Explore More Order eSpOT-ON Nuclease mRNA Now
My Cart
Contact Sales
Molecular Reagents

RPA vs. LAMP: Choosing the Right Isothermal Amplification Method for Modern Molecular Diagnostics

11 min read

Curious about the fastest, most efficient isothermal amplification methods for nucleic acid detection? Our quick guide breaks down the key differences between Recombinase Polymerase Amplification (RPA) and Loop-mediated Isothermal Amplification (LAMP)—from speed and temperature requirements to primer complexity—so you can confidently choose the best fit for your workflow and deployment needs.

Isothermal amplification enables molecular diagnostics outside the laboratory by eliminating the need for thermal cycling and simplifying instrumentation. Among these approaches, Recombinase Polymerase Amplification (RPA) and Loop-mediated Isothermal Amplification (LAMP) are often compared, but their mechanistic differences create important trade-offs in assay design and deployment.

RPA stands out when speed, low energy demand, and streamlined design matter most. Operating at near-physiological temperatures (37–42°C) and requiring only two primers per target, RPA can deliver amplification in as little as 10–20 minutes without complex thermal control or multi-primer optimization. It also maintains strong performance in crude samples and supports multiplexing—combining simplicity and robustness in a format well suited for point-of-care and portable molecular diagnostics.

RPA Kits Built for Simplicity and Speed

Looking to streamline your isothermal workflow? See how our optimized reagents can help you move from concept to results faster.

Explore Our RPA Kits
CTA Image

What Is Recombinase Polymerase Amplification (RPA)?

Recombinase Polymerase Amplification (RPA) is a rapid isothermal nucleic acid amplification method that operates at a constant 37–42°C, eliminating the need for thermocyclers. Unlike PCR, which uses heat to denature DNA, RPA relies on enzymes to access the template.

 

A recombinase (commonly derived from T4 bacteriophage) binds to primers to form a nucleoprotein filament that scans double-stranded DNA for homologous sequences. Upon finding a match, the primer invades the duplex without thermal denaturation. Single-stranded DNA-binding proteins stabilize the displaced strand, and a strand-displacing polymerase extends the primer.

 

Because the reaction runs continuously at near-physiological temperatures, amplification is rapid and exponential. Dive deeper into mechanisms, methods, and protocols in our RPA Guide for DNA targets or RT-RPA Guide for RNA targets.

Why It Matters for Diagnostics

For diagnostic developers, the recombinase-driven mechanism offers distinct operational advantages that can simplify your workflow:
  • Simplified Instrumentation: No thermal cycling hardware is required, reducing device complexity.
  • Low Energy Demand: Operation at 37–42°C minimizes power requirements for portable or battery-operated systems.
  • Rapid Kinetics: Assays typically deliver results in 10–20 minutes, enabling faster decision-making.

RPA’s ability to operate at lower temperatures makes it a superior candidate for portable, handheld diagnostic platforms where power and space are limited. In some applications, the reaction can even be performed without instrumentation—simply by holding the sample in the palm of your hand.

What Is Loop-Mediated Isothermal Amplification (LAMP)?

Loop-mediated Isothermal Amplification (LAMP) amplifies DNA at a constant, elevated temperature, typically between 60–65°C. It relies on a strand-displacing polymerase and a distinct, multi-primer architecture to drive amplification.

 

Unlike RPA, LAMP does not use a recombinase enzyme. Instead, it employs a DNA polymerase with high strand displacement activity (often Bst DNA polymerase). The reaction relies on a set of four to six primers that recognize six to eight distinct regions on the target DNA.

 

The inner primers initiate synthesis and create stem-loop structures. These loops facilitate self-priming, accelerating the reaction as it progresses. The result is the formation of complex concatemer structures and an immense accumulation of DNA product.

Why It Matters for Diagnostics

LAMP is renowned for its robustness and yield:
  • High Signal Strength: The massive amount of DNA produced allows for visual detection methods, such as turbidity or colorimetric changes.
  • Endpoint Readouts: Visual readouts can simplify workflows in low-resource settings.
However, the methodology introduces added design complexity. Because LAMP requires four to six primers per target, multiplex assay development demands careful optimization to minimize primer–primer interactions and nonspecific amplification. While multiplexed LAMP assays have been successfully demonstrated, expanding target panels generally increases the design and validation burden compared to two-primer systems such as RPA or PCR. Additionally, maintaining a constant 65°C requires greater thermal control and energy input than the lower temperatures used for RPA.

RPA vs. LAMP: Side-by-Side Comparison

For developers prioritizing field-deployable molecular testing, these differences become operationally significant.
Feature
LAMP
RPA
Temperature
60–65°C
37–42°C
Time to Result
30–60 minutes
10–20 minutes
Thermal Cycling
Not required
Not required
Primer Design
Complex
Simple
Primers per Target
4–6
2
Multiplexing
Yes
Yes
Detection Method
Endpoint & Real-Time
Endpoint & Real-Time

Image
Figure 1. Schematic overview of the operating mechanisms underlying the isothermal amplification methods LAMP and RPA. Adapted from Frontiers in Plant Science, Venbrux et al., 2023.

Strategic Advantages of RPA

As diagnostics move closer to the patient, performance requirements shift. If you are developing decentralized testing platforms, speed becomes paramount and hardware must remain minimalistic. In this context, RPA often outperforms LAMP for true point-of-care applications.

Performance without Molecular Complexity

RPA delivers multiplexing capabilities and robust performance with difficult samples comparable to LAMP, but it does so without requiring you to manage complex multi-primer sets or sustained high-temperature operation. By operating at near-ambient temperatures with a simplified dual-primer design, RPA provides a faster and more versatile diagnostic platform for both sophisticated clinical panels and rugged field applications.

Faster Results for Real-Time Decisions

In outbreak scenarios or environmental monitoring, waiting an hour for results is often impractical. RPA’s enzyme-driven kinetics allow for actionable results in as little as 10–20 minutes. This speed supports real-time decision-making, whether screening for pathogens or confirming contamination.

Simplified Hardware Design

RPA operates at 37–42°C—essentially body temperature—reducing the engineering complexity of the diagnostic device. Unlike LAMP, which requires sustained heating at 65°C, RPA platforms can be smaller, lighter, and more energy-efficient. This lower thermal burden simplifies field logistics and extends battery life for portable units.

Synthego Supports You At Every Step

Customized for Your Workflow

Every diagnostic platform has unique requirements, from detection chemistry to sample preparation and device architecture. Synthego offers customizable RPA reagents designed to integrate seamlessly into your workflow. Kit configurations can be tailored—including reagent volume, concentration, and formulation—to match your application, with options available in both liquid and lyophilized formats. This flexibility helps optimize assay performance while simplifying development and scale-up.

Lyophilization: Superior Stability for Point-of-Care Diagnostics

For decentralized and field-based testing, reagent stability is critical. Our RPA kits are available in lyophilized formats that enhance shelf life and simplify storage and transport. This stability enables reliable performance in environments where cold-chain logistics are challenging, supporting true point-of-care and field-deployable diagnostics. Read more about the importance of lyopholization in point-of-care diagnostics.

Flexible Options for DNA and RNA Detection

Diagnostic developers often need flexibility across assay types. Synthego offers four RPA kit formats to suit diverse workflows: RPA kits for DNA targets and RT-RPA kits for RNA detection, each available in both endpoint and real-time detection formats:

This structure allows you to select the best combination for your assay, whether detecting pathogens, monitoring biomarkers, or integrating with specialized instrumentation.

Customize Your Kit

Tailor your isothermal amplification workflows with customizable RPA kits designed to meet your specific diagnostic or research needs. From optimized reaction conditions to lyophilization, our flexible solutions ensure precision and reliability for any application.

Get In Touch
two office workers looking at a laptop

Real-World Applications

Both technologies have found their niches in molecular diagnostics. LAMP is widely used in agricultural settings and simple screening tests where high-throughput visual readouts are valuable, such as lyophilized colorimetric RT-LAMP test kits for SARS-CoV-2.

 

However, RPA is increasingly favored for sophisticated, decentralized testing platforms. Its compatibility with lateral flow strips, fluorescence detection, and microfluidic integration makes it the engine behind next-generation field surveillance systems and rapid infectious disease platforms. Furthermore, the integration of RPA with CRISPR/Cas creates a powerful synergy where the rapid isothermal amplification of RPA is coupled with the precise, RNA-guided target recognition of the Cas protein, enabling highly sensitive and specific visual detection without the need for complex laboratory hardware.

The Future of Isothermal Amplification

The future of diagnostic testing lies in portable, distributed platforms. Technologies that combine speed, stability, multiplexing, and low infrastructure requirements will define this new era.
While LAMP offers high yields for single-target visual assays, RPA provides a versatile foundation for rapid, multiplexed, and instrument-light diagnostics. By leveraging lyophilized endpoint and real-time RPA formats, developers can build robust solutions for:
  • Point-of-care diagnostic tests
  • Lab-based, rapid infectious disease platforms
  • Field-based surveillance systems
  • Low-resource molecular testing
If you are building rapid, multiplexed, or field-ready molecular diagnostics, RPA offers a flexible foundation that balances speed, simplicity, and performance within the isothermal toolkit.

Explore the Full Molecular Diagnostics Portfolio

Explore Synthego’s full molecular portfolio — from PCR & RT enzymes and IVT enzymes to isothermal amplification and sample preparation & processing — to empower your next molecular or clinical diagnostic breakthrough.

Learn More
CTA Image
FILED IN
MOLECULAR REAGENTS
POSTED: March 6, 2026

Ready to get started?

Get in touch

Related Articles

Let us be your Guide

We're here to help you find the best CRISPR solution for your project.

Schedule a call today